Pictet Asset Management (Switzerland)’s Molecular Templates, Inc. MTEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-121,394
Closed -$597K 2046
2022
Q4
$597K Sell
121,394
-72,151
-37% -$597K ﹤0.01% 1174
2022
Q3
$2.18M Hold
193,545
﹤0.01% 912
2022
Q2
$2.65M Sell
193,545
-20,342
-10% -$476K ﹤0.01% 892
2022
Q1
$11.1M Sell
213,887
-6,181
-3% -$273K 0.01% 624
2021
Q4
$12.9M Sell
220,068
-5,730
-3% -$429K 0.01% 607
2021
Q3
$22.7M Buy
+225,798
New +$23.3M 0.03% 486

Other funds holding MTEM

Pictet Asset Management (Switzerland)'s MTEM Position: Q1 2023 in Review

Pictet Asset Management (Switzerland) sold out of Molecular Templates, Inc. (MTEM) in Q1 2023, closing a stake of 121,394 shares — an estimated $597K sold.

Pictet Asset Management (Switzerland) first reported a position in MTEM in Q3 2021 and held it in 6 quarters. The position peaked at $22.7M in Q3 2021. 41 funds tracked by Wall St. Rank hold MTEM as of Q1 2023.

  • Pictet Asset Management (Switzerland) reported no remaining Molecular Templates, Inc. position as of Q1 2023 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 121,394 Molecular Templates, Inc. shares in Q1 2023, an estimated $597K.
  • Pictet Asset Management (Switzerland) first reported a position in Molecular Templates, Inc. in Q3 2021 and held it in 6 quarters.
  • Pictet Asset Management (Switzerland)'s Molecular Templates, Inc. position peaked at $22.7M in Q3 2021.
  • 41 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q1 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q1 2023, filed 10 May 2023.